Search
for
Sort by
Research 91–120 of 790
- Janus kinase inhibition for the treatment of refractory frontal fibrosing alopecia: A case series and review of the literature
- Tofacitinib for the treatment of severe alopecia areata and variants: A study of 90 patients
- Selective inhibition of JAK3 signaling is sufficient to reverse alopecia areata
- Successful Treatment of Refractory Alopecia Areata Universalis and Psoriatic Arthritis, But Not of Plaque Psoriasis with Tofacitinib in a Young Woman
- Efficacy of tofacitinib in pediatric alopecia universalis
- Small Molecule Inhibitors and Inflammatory Skin Diseases
- An urticarial drug eruption caused by tofacitinib for alopecia universalis
- Successful treatment with upadacitinib in concurrent atopic dermatitis, Crohn’s disease, alopecia areata, and eosinophilic gastropathy in a pediatric patient
- Upadacitinib Efficacy for the Treatment of Concomitant Psoriasis and Alopecia Areata
- Killing Two Birds with One Stone: Oral Tofacitinib Reverses Alopecia Universalis in a Patient with Plaque Psoriasis
- Alopecia Areata: a Comprehensive Review of Pathogenesis and Management
- A novel therapeutic paradigm for patients with extensive alopecia areata
- Current and future pharmacotherapy for alopecia areata
- Unexpected Extensive Hair Whitening Following Baricitinib Treatment for Alopecia Universalis: A Case Report and Mechanistic Insights
- Markers of Venous Thromboembolism Risk in Patients with Alopecia Areata: Is There Anything to Worry about?
- An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch-Type Alopecia Areata, Totalis, and Universalis
- A review of Janus kinase inhibitor use in scarring alopecia
- JAK1 gain-of-function variant causes alopecia areata, atopic dermatitis, and autoimmune thyroid disease
- Upadacitinib in the treatment of a patient with the triad of atopic dermatitis, vitiligo, and alopecia areata: a case report and literature review
- Significant improvement with ivarmacitinib after suboptimal response to tofacitinib in severe alopecia areata: a case report and literature review
- The development of oral hairy leukoplakia during JAK inhibitor baricitinib therapy
- Upadacitinib in dermatologic therapy: Emerging evidence and expanding indications
- Upadacitinib for the Treatment of Systemic Immune Co-Morbidity in One Case: Alopecia Areata, Vitiligo, Ankylosing Spondylitis, and Allergic Rhinitis-Asthma – Multifaceted Control
- Alopecia Areata
- Alopecia Areata
- A pilot study of 2% tofacitinib cream with narrowband ultraviolet B for the treatment of facial vitiligo
- Complete Regrowth of Beard Hair with Ruxolitinib in an Alopecia Universalis Patient
- Peripheral neuropathy associated with tofacitinib use in alopecia universalis
- Off-Label Uses of Abrocitinib: Review of Emerging Therapeutic Applications beyond Atopic Dermatitis
- Atopic Dermatitis and Multilocular Alopecia Areata Simultaneously Treated With Baricitinib